A framework for measuring costs to society of IgE-mediated food allergy

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 60, Issue 8, 2005, Pages 996-1003

  Miles, S ^a   Fordham, R ^a   Mills, C ^b   Valovirta, E ^c   Mugford, Miranda ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^c EFA European Federation of Allergy and Airways Diseases Patients' Associations   (Belgium)

Author keywords

Cost of illness; Economic impact; Food allergy

Indexed keywords

IMMUNOGLOBULIN E;

BEHAVIOR; CONSUMER; COST OF ILLNESS; ECONOMIC ASPECT; FOOD ALLERGY; FOOD INDUSTRY; HEALTH CARE PLANNING; HUMAN; MEASUREMENT; NUTRITIONAL INTOLERANCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SOCIETY;

COST OF ILLNESS; FOOD HANDLING; FOOD HYPERSENSITIVITY; FOOD LABELING; HEALTH CARE COSTS; HUMANS; IMMUNOGLOBULIN E; QUALITY OF LIFE;

EID: 21744449681     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2005.00868.x     Document Type: Review

References (53)

1. Bock SA. Prospective appraisal of complaints of adverse reactions to foods in children during the first 3 years of life. Pediatrics 1987;79:683-688.
2. Sicherer SH. Food allergy. Lancet 2002;360:701-710.
3. Burks AW, Stanley JS. Food allergy. Curr Opin Pediatr 1998;10:588-593.
4. Woods RK, Stoney RM, Raven J, Walters EH, Abramson M, Thien FCK. Reported adverse food reactions over-estimate true food allergy in the community. Eur J Clin Nutr 2002;56:31-36.
5. Perry TT, Matsui EC, Kay Conover-Walker M, Wood RA. The relationship of allergen-specific IgE levels and oral food challenge outcome. J Allergy Clin Immunol 2004;114:144-149.
6. Eigenmann PA, Sampson HA. Interpreting skin prick tests in the evaluation of food allergy in children. Pediatr Allergy Immunol 1998;9:186-191.
7. Niggemann B, Reibel S, Wahn U. The atopy patch test (APT) - a useful tool for the diagnosis of food allergy in children with atopic dermatitis. Allergy 2000;55:281-285.
8. Johansson SGO, Hourihane JO'B, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T et al. A revised nomenclature for allergy. Allergy 2001;56:813-824.
9. Gold M, Segal J, Russell L, Weinstein M (editors). Cost effectiveness in health and medicine. New York, USA: Oxford University Press, 1996.
10. Drummond M, O'Brien B, Stoddart G, Torrance G. Methods for the economic evaluation of health care programmes, 2nd edn. Oxford, UK: Oxford University Press, 1997.
11. Williams RD. An introduction to the UK time use survey from a labour market perspective: how the survey can be analysed to gain a better understanding of labour market behaviour. Labour Market Trends 2004;112:8 http://www.statistics.gov.uk/timeuse (Accessed 15 March 2005)
12. Drummond M. Cost of illness studies. A major headache? PharmacoEconomics 1992;2:1-4.
13. Rice DP. Cost of illness studies: fact or fiction? Lancet 1994;344:1519.
14. Rendu A, Moran P, Patel A, Knapp M, Mann A. Economic impact of personality disorders in UK in primary care attenders. Br J Psychiatry 2002;181:62-66.
15. HM Treasury. The green book: appraisal and evaluation in central government - treasury guidance. London. UK: The Stationary Office, http://greenbook.treasury.gov.uk/2003
16. Cooper NJ, Mugford M, Symmons DPM, Barrett EM, Scott DGI. Total costs and predictors of costs in individuals with early inflammatory polyarthritis: a community-based prospective study. Rheumatology 2002;41:767-774.
17. The UCB Institute of Allergy. European Allergy White Paper. Brussels: The UCB Institute of Allergy, 1997.
18. Bolin K, Lindgren B. Asthma and allergy: the significance of chronic conditions for individual health behaviour. Allergy 2002;57:115-122.
19. Blaiss MS. Cognitive, social, and economic costs of allergic rhinitis. Allergy Asthma Proc 2000;21:7-13.
20. National Institute for Clinical Excellence (NICE). Guidance on the use of inhaler systems (devices) in children under the age of 5 with chronic asthma. National Institute for Clinical Excellence, Report 10. ISBN 1-84257-033-1. http://www.nice.org.uk/ (Accessed 15 March 2005).
21. Confino-Cohen R, Melamed S, Goldberg A. Debilitating beliefs, emotional distress and quality of life in patients given immunotherapy for insect sting allergy. Clin Exp Allergy 1999; 29:1626-1631.
22. The UCB Institute of Allergy. European Allergy White Paper: update. Brussels: The UCB Institute of Allergy, 1999.
23. Yelin E, Trupin L, Cisternas M, Eisner M, Katz P, Blanc P. A national study of medical care expenditures for respiratory conditions. Eur Respir J 2002;19:414-421.
24. Smith J, Mugford M, Candy B, Holland R, Noble M, Harrison B et al. A systematic review to examine the impact of psycho-educational interventions on health outcomes and costs in adults and children with difficult asthma. Health Technol Assess March 2005 (in press).
25. Rico-Méndez FG, Barquera S, Cabrera DA, Escobedo S, Ochoa LG, Massey-Reynaud LF. Bronchial asthma health-care costs in Mexico: analysis of trends from 1991-1996 with information from the Mexican Institute of Social Security. Invest Allergol Clin Immunol 2000;10:334-341.
26. Food Standards Agency. May contain labelling - the consumer's perspective. http://www.foodstandards.gov.uk/ multimedia/pdfs/maycontainreport. pdf, 2002.
27. Fireman P. Treatment of allergic rhinitis: effect on occupation productivity and work force costs. Allergy Asthma Proc 1997;18:63-67.
28. Burton WN, Conti DJ, Chen C, Yschultz AB, Edington DW. The impact of allergies and allergy treatment on worker productivity. J Occup Environ Med 2001;43:64-71.
29. Kozma CM, Sadik MK, Watrous ML. Economic outcomes for the treatment of allergic rhinitis. Pharmaco Economics 1996;10:4-13.
30. Crystal-Peters J, Crown WH, Goetzel RZ, Schutt DC. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care 2000;6:373-378.
31. Koopmanschap MA, Brouwer WB. Indirect costs and costing informal health care. In: Wino A, Johnson B, Karlsson G, Winblad B, editors. Health economics of dementia. Chichester: John Wiley & Sons, 1998:245-265.
32. Ward MM, Javitz HS, McFate Smith W, Whan MA. Lost income and work limitations in persons with chronic respiratory disorders. J Clin Epidemiol 2002;55:260-268.
33. Kemp AS. Atopic eczema: its social and financial costs. J Paediatr Child Health 1999;35:229-231.
34. Fernandez-Rivas M, Miles S. Food allergies: clinical and psychosocial perspectives. In: Mills ENC, Shewry PR, editors. Plant food allergens. Oxford, UK: Blackwell Science Ltd, 2004:1-23.
35. Graham M, Blaiss MS. Quality of life outcomes measures of asthma and allergic rhinitis. Pediatr Ann 2000;29:438-443.
36. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108:545-553.
37. Baiardini I, Pasquali M, Giardini A, Majani G, Canonica GW. Quality of life in respiratory allergy. Allergy Asthma Proc 2001;22:177-181.
38. Brouwer W, Rutten F, Koopmanschap M. Costing in economic evaluations. In: Drummond M, McGuire A. editors. Economic evaluation in health care: merging theory with practice. Oxford and New York: Office of Health Economics and Oxford University Press, 2001:63-93.
39. Brouwer Werner BF, Koopmanschap M, Rutten F. Patient and informal caregiver time in cost-effectiveness analysis. A response to the recommendations of the Washington Panel. Int J Technol Assess Health Care 1998;14:505-513.
40. Hourihane JO'B. The threshold concept in food safety and its applicability to food allergy. Allergy 2001; 56(Suppl. 67):86-90.
41. Gowland MH. Food allergen avoidance: risk assessment for life. Proc Nutr Soc 2002;61:39-43.
42. Muñoz-Furlong A. Daily coping strategies for patients and their families. Pediatrics 2003;111:1654-1661.
43. Primeau MN, Kagan R, Joseph L, Lim H, Dufresne C, Duffy C et al. The psychological burden of peanut allergy as perceived by adults with peanut-allergic children. Clin Exp Allergy 2000;30:1135-1143.
44. Sicherer SH, Noone SA, Muñoz-Furlong A. The impact of childhood food allergy on quality of life. Ann Allergy Asthma Immunol 2001;87:461-464.
45. Watura JC. Nut allergy in schoolchildren: a survey of schools in the Severn NHS Trust. Arch Dis Child 2002;86:240-244.
46. Foucard T, Mahlmeden-Yman I. A study on severe food reactions in Sweden. Is soy protein an underestimated cause of food anaphylaxis? Allergy 1999;54:261-265.
47. Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001;107:191-193.
48. Young E, Stoneham MD, Petruckevitch A, Barton J, Rona R. A population study of food intolerance. Lancet 1994;343:1127-1130.
49. Price CE, Rona R, Chinn S. Height of primary school children and parents' perceptions of food intolerance. BMJ 1988;296:1696-1699.
50. Lang T, Heasman M. Food wars: the global battle for mouths, minds and markets. London, UK: Earthscan, 2004.
51. Polunin M. Freedom foods. Org Nat Bus 2004;4:16-17.
52. Beecham C. Establishment and consequences of a nut-free environment. Food Allergy Intolerance 2000;1:201-206.
53. Codex General Standard for the Labelling of Prepackaged Foods, Codex Alimentarius, Food Labelling, Complete Texts. Rome: Joint FAO/WHO Food Standards Program, Codex Commission, 2001.